Ankekang Biopharmaceutical headquarters details
- Founded
- 2018
- Website
- ancocare.com
About Ankekang Biopharmaceutical
Ankekang Biopharmaceutical: Pharmaceutical company founded in 2018. Founded in 2018, the company employs approximately 5 people worldwide.
What does Ankekang Biopharmaceutical do?
Ankekang Biopharmaceutical is described as a biotechnology company focused on developing a Flavivirus technology platform and advancing innovative treatments, such as immune oncolytic viruses, replicating nucleic acid drugs, and tumor vaccines. Its goal is to offer new immune oncolytic therapies for cancer patients globally, backed by a core technology platform with independent intellectual property, and encompassing the full industrial chain from preclinical research to production.
Frequently asked questions
When was Ankekang Biopharmaceutical founded?
Ankekang Biopharmaceutical was founded in 2018 and employs approximately 5 people.
How many employees does Ankekang Biopharmaceutical have?
Ankekang Biopharmaceutical has approximately 5 employees (GraphIQ estimate, 2026).